Manufacturing / Pharmaceutical Preparations
Sarepta Therapeutics, Inc.
SRPT
$20.12
-$0.56 (-2.71%)
Price as of Sep 18, 2026 22:57 UTC
1.8 B
Market Cap (Small Cap)
42%
IV Rank
85.7%
Implied Volatility
Nov 02
Next Earnings
Technical Signals
as of Sep 16
Mixed
4 of 7
Trend
- Above 20-day average $20.38
- Above 50-day average $19.24
- Above 200-day average $19.23 · +2.7%
- Moving averages stacked 20 > 50 > 200
Momentum
- Golden cross (50/200) today
- Momentum cross (20/50) 19d ago
Volume
- Below-average volume 0.8x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.12
Bullish skew
Implied Volatility
85.7%
1% percentile
IV vs Realized
Options rich
30d HV 66.6%
Options Heat Map
Delta-risk grid for SRPT options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
2 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Jul 28, 2026 | SEVERINO MICHAEL | Grant | 2,224,342 | $0 | +30.3% | |
| Jul 28, 2026 | SEVERINO MICHAEL | Grant | 756,104 | $0 | +30.3% | |
| Jun 04, 2026 | Chambers Michael Andrew | Grant | 16,875 | $0 | +20.7% | |
| Jun 04, 2026 | Nicaise Claude | Grant | 16,875 | $0 | +20.7% | |
| Jun 04, 2026 | Wigzell Hans Lennart Rudolf | Grant | 16,875 | $0 | +20.7% | |
| Jun 04, 2026 | Boor Kathryn Jean | Grant | 16,875 | $0 | +20.7% | |
| Jun 04, 2026 | Wigzell Hans Lennart Rudolf | Other | 16,875 | $0 | +20.7% | |
| Jun 04, 2026 | Barry Richard | Grant | 16,875 | $0 | +20.7% | |
| Jun 04, 2026 | Connelly Deirdre P | Grant | 16,875 | $0 | +20.7% | |
| Jun 04, 2026 | BEHRENS M KATHLEEN | Grant | 16,875 | $0 | +20.7% |
Politician Trades in SRPT
| Date | Politician | Party | Type | Amount | Since Buy |
|---|---|---|---|---|---|
| Apr 14, 2025 | Gil Cisneros | D | Sale | $1K-$15K | — |
| Jul 14, 2023 | Josh S. Gottheimer | D | Purchase | $1K-$15K | -81.4% |
| Jun 13, 2023 | Josh S. Gottheimer | D | Sale | $1K-$15K | — |
| Apr 10, 2023 | Daniel Goldman | D | Sale | $15K-$50K | — |
| Mar 06, 2023 | Josh S. Gottheimer | D | Purchase | $1K-$15K | -87.1% |
| Mar 06, 2023 | Daniel Goldman | D | Purchase | $15K-$50K | -87.1% |
| Jan 31, 2023 | Daniel Goldman | D | Sale | $1K-$15K | — |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 05, 2026 | Q2 2026 | $0.26 | |||
| Aug 04, 2026 | Q2 2026 | $0.27 | |||
| Jun 30, 2026 | Q2 2026 | $0.26 | $0.64 | +143.8% | Beat |
| Mar 31, 2026 | Q1 2026 | $1.01 | $2.88 | +184.7% | Beat |
| Dec 31, 2025 | Q4 2025 | -$1.26 | -$3.93 | -213.0% | Miss |
| Sep 30, 2025 | Q3 2025 | -$0.83 | -$0.01 | +98.8% | Beat |
| Jun 30, 2025 | Q2 2025 | $0.77 | $1.89 | +146.8% | Beat |
| Mar 31, 2025 | Q1 2025 | -$0.97 | -$4.60 | -376.2% | Miss |
Track SRPT with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for SRPT and your entire portfolio.